Clinicians referring patients for imaging with nuclear and molecular modalities will soon be able to do so with ready access to utilization assistance that’s based on appropriate-use criteria developed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
That’s because the group is working with National Decision Support Company (NDSC) to put the criteria in front of these referrers, as long as they use NDSC’s widely adopted Care Select Imaging platform, according to a news release sent by NDSC.
The company notes that the Protecting Access to Medicare Act of 2014 requires ordering clinicians to check appropriate-use criteria before ordering advanced imaging. Only criteria developed by entities meeting CMS’s qualified provider-led entity (PLE) standards can be used under the program, NDSC points out, adding that SNMMI won qualified-PLE status in June 2016.
NDSC says its CareSelect platform “assures providers that criteria are developed through proven processes that reflect the collective experience of providers on a national scale, without bias and independent of economic agendas.”
The SNMMI appropriate-use criteria will be available in the fall, according to the news release.